Solid performance in context of COVID-19 market challenges Healthy longer-term commercial momentum with large, signature project wins Company to report second quarter earnings July 30, 2020 RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 14, 2020– Global water technology company, Xylem Inc. (NYSE:XYL), today announced that for the quarter ended June 30, 2020, it expects revenue declines of approximately... Read more
WASHINGTON, July 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2020 on Thursday, July 23, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 13, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates growth in both reported revenue and organic revenue1 of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven by better-than-expected demand for PerkinElmer’s full-suite... Read more
We’re thrilled to share that ParticleScout, our automated microparticle analysis tool, has been chosen as a finalist for the 2021 Wiley Analytical Science Award! This distinction from a neutral jury of researchers and industry representatives includes ParticleScout among six nominated products in the “Spectroscopy & Microscopy” category. Now, the readers of “GIT Labor-Fachzeitschrift”, “Imaging & Microscopy”... Read more
Thermo Fisher Scientific Provides Update to Second Quarter Outlook and Will Hold its Q2 Earnings Conference Call on Wednesday, July 22, 2020 WALTHAM, Mass., July 6, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that, based on currently available information, it estimates that both reported and... Read more
Venlo, the Netherlands, June 23, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that according to the intended business combination between Invitae (NYSE: NVTA) and ArcherDX, QIAGEN could realize a significant pre-tax capital gain from its minority investment in ArcherDX, a U.S.-based genomics analysis company involved in precision oncology. As of June... Read more
Company’s latest FDA EUA solution broadens RT-PCR and serology offerings available in the U.S. WALTHAM, Mass. – June 15, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer Company, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for... Read more
Dr. Hunkapiller to retire by the end of 2020 Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end workflow extends the options... Read more
Chicago, Illinois – June 9, 2020 – To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today announced the Food and Drug Administration’s 510(k) clearance of Pristina Serena Bright™*, the healthcare industry’s first contrast-enhanced mammography solution for https://www.genewsroom.com/press-releases/ge-healthcare-receives-fda-clearance-industry%E2%80%99s-first-contrast-enhanced-mammography Read more